Each week we highlight five things affecting the life sciences industry. Here's the latest. Biopharma research productivity increases Recent advancements in artificial intelligence are significantly enhancing research and development productivity by streamlining drug discovery processes, leading to ... READ MORE >
life sciences
5 things to know in life sciences: Week of May 27, 2024
Each week we highlight five things affecting the life sciences industry. Here's the latest. FDA issues draft guidance on platform technology designation The Food and Drug Administration has released a draft guidance aimed at providing a framework for the designation of platform technologies, which ... READ MORE >
5 things to know in life sciences: Week of May 20, 2024
Each week we highlight five things affecting the life sciences industry. Here's the latest. New collaboration explores AI-based digital pathology Microsoft is collaborating with researchers from the University of Washington as well as Providence health network to develop a new artificial ... READ MORE >
5 things to know in life sciences: Week of May 13, 2024
Each week we highlight five things affecting the life sciences industry. Here's the latest. FDA approves new self-collection approach to cervical cancer screening According to the Washington Post, the Food and Drug Administration has approved a newly developed screening test for cervical cancer that ... READ MORE >
New tariffs on medical equipment could strain health care and life sciences supply chains
Health care and life sciences organizations’ operations could be affected by recent tariff increases on Chinese medical equipment imports as part of a broader economic regime shift to embrace industrial policy. The Biden administration, in an effort to address what it calls unfair trade policies and ... READ MORE >
5 things to know in life sciences: Week of May 6, 2024
Each week we highlight five things affecting the life sciences industry. Here's the latest. Biopharma industry challenges Biosecure Act BioCentury reports that the biopharma industry is actively lobbying for changes to the Biosecure Act aiming to modify legislative measures that could impact U.S. ... READ MORE >
5 things to know in life sciences: Week of April 29, 2024
Each week we highlight five things affecting the life sciences industry. Here's the latest. FDA releases final rule on laboratory developed tests On April 29, the U.S. Food and Drug Administration issued a final rule regarding regulation of laboratory developed tests, following a proposed rule in ... READ MORE >
Key takeaways for life sciences on laboratory developed tests final rule
The U.S. Food and Drug Administration released a final rule yesterday regarding the regulation of laboratory developed tests, also known as LDTs. This final rule follows a proposed rule that was released last fall. While the final rule closely follows the proposed rule released late last year, there are ... READ MORE >
5 things to know in life sciences: Week of April 22, 2024
Each week we highlight five things affecting the life sciences industry. Here's the latest. Orphan drug market to reach $270 billion by 2028 despite decreasing growth rates According to data from Evaluate, the orphan drug market is projected to expand to $270 billion by 2028. This sector, while ... READ MORE >
5 things to know in life sciences: Week of April 15, 2024
Each week we highlight five things affecting the life sciences industry. Here's the latest. EU launches probe into China's medical device market practices According to Reuters, the European Union is set to begin an investigation into China's medical device procurement practices, concerned that ... READ MORE >